AUBURN, Wash.--(BUSINESS WIRE)--Syntrix Biosystems, Inc., is pleased to announce that a federal court in Tacoma, Washington, has granted the company a final judgment of $115 million in a patent ...
Will ignore decision as it appeals the ruling, saying process could take years. Strongly disagreeing with the jury's findings, Illumina said it will ignore the decision as it intends to file motions ...
NEW YORK, March 3, 2026 /PRNewswire/ -- LivePerson (NASDAQ: LPSN), a leading provider of predictable conversational AI, today announced the launch of Syntrix, a groundbreaking simulation and ...
The company provided 2026 guidance of revenue between $195 million and $207 million and adjusted EBITDA between a loss of $4 million and a gain of $7 million. Sabino noted, "While this guidance ...
SAN DIEGO (AP) -- Genetic analysis instrument company Illumina Inc. on Monday reported a loss in the first quarter after a federal jury found it infringed on a patent belonging to Syntrix Biosystems.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Auburn biotech Syntrix Biosystems Inc. said its $115 ...
Brands are now able to quickly scale customer-facing AI agents with confidence and verify live agent readiness across CX NEW YORK, March 3, 2026 /PRNewswire/ -- LivePerson (NASDAQ: LPSN), a leading ...